Sentence examples for increased progression from inspiring English sources

In a phase IIb/III trial, afatinib increased progression free survival (3.3 months) of patients with advanced NSCLC that progressed after treatment with erlotinib, gefitinib, or both compared to placebo group (1.1 months P < 0.0001) [36].

"There is now strong evidence relating greater depressive symptoms to increased progression from normal cognition to mild cognitive impairment and from mild cognitive impairment to dementia," Dr. Donovan and colleagues reported, citing their findings and those of others.

Such loss of functions would result in reduced ability of DJ-1 to protect from oxidative stress insults and may lead to increased progression of disease.

DAT-KO treated mice did not show increased progression of clasping scores during the 15-second tail suspension test, while KO control animals exhibited higher clasping and dorsal kyphosis scores starting from day 24 onwards when compared to the treated KO group (two-way ANOVA, F 4,160) = 5.631, p = 0.0003; Holm-Sidak post-hoc p = 0.0016 Day 24; p < 0.0001 for Day 36 and Day 48 Fig. 7E).

We have seen in Figure 10, that AQP3 has a reduced expression with increased progression in our melanoma dataset.

In the present study, we conjectured that the absence of cystatin C caused increased cathepsin expression and activities (Figures 3 6) and enhanced pro-angiogenic γ2 production with promotion of angiogenesis, leading to increased progression to SCC (Figure 2).

The GOG-218 and ICON-7 studies recently showed that adding bevacizumab to first-line therapy for patients with advanced ovarian cancer increased progression-free survival.

Results of a trial in 666 women with advanced breast cancer, presented at the American Society of Clinical Oncology ASCOO) meeting in Chicago, showed the combination increased progression-free survival for a median 24.8 months compared with 14.5 months for letrozole alone.

When combined with chemotherapy in the drug's critical phase III trial, Avastin increased progression-free survival for the average metastatic breast cancer patient by 5.5 months.

Zhang et. al. first reported that patients with CD3+ T cell infiltrates in tumor epithelium had increased progression-free and overall survival [8].

In patients affected with oligodendroglioma this genotype is associated with increased progression-free and overall survival as well as a better responsiveness to durable response to chemotherapy [4], [10], [11], [12].